Effectiveness of Extracorporeal Shockwave Therapy Combined With Platelet-rich Plasma in the Treatment of Chronic Insertional Achilles Tendinopathy
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: ESWT, PRP.
- Who it may be relevant to
- Registry conditions: Insertional Achilles Tendinopathy. Basic parameters: 18 years — 70 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Thailand
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The goal of this clinical trial is to learn about the effectiveness of extracorporeal shockwave(ESWT) combined with platelet-rich plasma(PRP) to treat chronic insertional tendinopathy. The main questions it aims to answer are: Does ESWT combined with PRP treatment reduce the symptom and improve functional score after treatment? What medical complication do participants have when receive the treatment? Researchers will compare ESWT combined with PRP to ESWT treatment alone to see if ESWT combined with PRP works to treat chronic insertional tendinopathy. Participants will: * Receive ESWT once a week for 4 weeks then receive PRP injection at a week later or ESWT once a week for 4 weeks * Visit the clinic at 6 weeks, 3 months, 6 months and 1 year after treatment for checkups and record functional score
Interventions
- Device ESWT
Receive ESWT once a week for 4 weeks - Biological PRP
Receive PRP injection at week 5
Primary outcome measures
- VAS [Time frame: 6 week, 3 months, 6 months and 1 year after treatment]
Secondary outcome measures (3)
- VAS-FA [Time frame: 6 week, 3 months, 6 months and 1 year after treatment]
- FFI [Time frame: 6 week, 3 months, 6 months and 1 year after treatment]
- FAAM [Time frame: 6 week, 3 months, 6 months and 1 year after treatment]
Eligibility criteria
Inclusion criteria
- Diagnosed with insertional Achilles tendinopathy
- Had symptom more than 6 months
- Failed other standard conservative treatment (rest, medication, activity modification, stretching exercise, and heel lift orthosis)
Exclusion criteria
- Receive corticosteroid injection at the Achilles insertion
- History of infection around ankle and heel
- Has neurological deficit
- Has a contraindication for ESWT(hemophilia, coagulopathy or foot and ankle malignancy)
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Thailand · 1 center
- Ramathibodi hospital — Ratchathewi
Identifiers
NCT: NCT06384859 · Pending